What's Going On With Moderna Shares Tuesday?

Moderna, Inc. MRNA shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 vaccine.

What Happened: Moderna announced on Tuesday that Health Canada approved its vaccine, SPIKEVAX, which aids in preventing COVID-19 in people six months of age or older.

The vaccine targets the KP.2 variant of COVID-19. The company plans to begin delivery of the vaccine to the Public Health Agency of Canada shortly.

The approval by Health Canada relies on a blend of manufacturing data, pre-clinical findings and earlier clinical, non-clinical and real-world evidence validating the efficacy and safety of Moderna’s mRNA vaccines for COVID-19.

“With the recent increase in COVID-19-infections, staying up to date with your COVID-19 vaccination remains one of the best ways to help protect yourself from severe illness,” said Dr. Shehzad Iqbal, country medical director, Moderna Canada.

How To Buy Moderna Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Moderna MRNA's case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

See Also: Clearmind Medicine Files International Patent For Ibogaine Combination Therapy

MRNA Price Action: At the time of publication, Moderna stock is moving 5.74% higher at $73.14 per data from Benzinga Pro.

Image: Photo via Wikimedia Commons